| 1 |
30396964 | Patients with hMLH1 or/and hMSH2-deficient Metastatic Colorectal Cancer Are Associated with Reduced Levels of Vascular Endothelial Growth Factor-1 Expression and Higher Response Rate to Irinotecan-based Regimen. | 2018 Nov |
1 |
| 2 |
30519050 | Association of MLH1 single nucleotide polymorphisms with clinical outcomes of first-line irinotecan-based chemotherapy in colorectal cancer. | 2018 |
3 |
| 3 |
28586388 | A prospective pilot study of genome-wide exome and transcriptome profiling in patients with small cell lung cancer progressing after first-line therapy. | 2017 |
1 |
| 4 |
23653048 | Influence of MLH1 on colon cancer sensitivity to poly(ADP-ribose) polymerase inhibitor combined with irinotecan. | 2013 Jul |
4 |
| 5 |
23724141 | MSH3 mismatch repair protein regulates sensitivity to cytotoxic drugs and a histone deacetylase inhibitor in human colon carcinoma cells. | 2013 |
1 |
| 6 |
19739070 | Mismatch repair system decreases cell survival by stabilizing the tetraploid G1 arrest in response to SN-38. | 2010 Jun 15 |
4 |
| 7 |
18941461 | Microsatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell lines. | 2008 Nov 18 |
1 |
| 8 |
17465213 | CPT-11 (SN-38) chemotherapy may be selectively applicable to biliary tract cancer with low hMLH1 expression. | 2007 Mar-Apr |
5 |
| 9 |
20368829 | Responsiveness of CPT-11 in respect to hMLH1 and hMSH2 protein expression in the primary colorectal cancer. | 2004 Dec |
4 |
| 10 |
12209584 | Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status. | 2002 Sep 1 |
1 |
| 11 |
12370755 | Phosphorylation of chk1 at serine-345 affected by topoisomerase I poison SN-38. | 2002 Nov |
1 |